Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO
- 25 July 2013
- journal article
- practice guideline
- Published by Wiley in British Journal of Haematology
- Vol. 162 (6), 758-773
- https://doi.org/10.1111/bjh.12463
Abstract
No abstract availableKeywords
This publication has 117 references indexed in Scilit:
- Acquired factor XIII deficiency: a therapeutic challengeThrombosis and Haemostasis, 2013
- Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)Blood, 2012
- Guidelines on the investigation and management of antiphospholipid syndromeBritish Journal of Haematology, 2012
- The relevance of the bleeding severity in the treatment of acquired haemophilia – an update of a single‐centre experience with 67 patientsHaemophilia, 2010
- Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patientsAmerican Journal of Hematology, 2009
- Factor XIII deficiencyHaemophilia, 2008
- Severe intracranial hemorrhage in a newborn infant with transplacental transfer of an acquired factor VIII:C inhibitorThe Journal of Pediatrics, 1995
- Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppressionAnnals of Hematology, 1995
- Bleeding tendency caused by IgG inhibitor to factor XIII, treated successfully by cyclophosphamideBritish Journal of Haematology, 1988
- Spontaneously acquired factor IX inhibitor in a nonhemophiliac childThe Journal of Pediatrics, 1978